In 2022, Saudi Aramco secured 963 US patents — tying for first place in the Houston metropolitan area — while ExxonMobil filed 281, an 8% decline. That asymmetry is not an energy story. It is a signal about where the next war is being fought.

This episode maps the structural transition from petrodollar hegemony to what we call the patent dollar: the deliberate weaponization of US intellectual property enforcement as the primary mechanism of global economic control. As BRICS+ nations deploy mBridge and BRICS Pay to bypass SWIFT and dollar-denominated clearinghouses, the United States is not retreating — it is relocating the chokepoint from the financial routing layer to the physical border and the courtroom.

The enforcement stack is precise. The UFLPA's rebuttable presumption standard places the entire burden of supply chain provenance on the importer — down to the specific quartz mine. PAIPA grants the executive branch authority to impose BIS Entity List designation, Export-Import Bank denial, and asset blocking with zero judicial determination. The SAFE Act of 2025 cuts federal STEM funding to any researcher with a history of collaboration with China's Seven Sons of National Defence, sealing the upstream knowledge pipeline. The Protecting Our Courts from Foreign Manipulation Act of 2023 targets the $16.1 billion TPLF industry after the Purplevine IP/Samsung case illustrated how foreign state actors use the discovery process as a legal extraction mechanism.

The counter-argument — that BRICS+ financial sovereignty renders US IP enforcement irrelevant — fails at the port. Patent enforcement does not require access to bank accounts. A USITC Section 337 exclusion order is entirely agnostic to whether the cargo was settled in e-CNY over mBridge or physical gold.

By the close of this episode, the listener will understand that financial routing strategy and IP strategy are not the same architecture. Conflating them is the operational error that ends companies.

The Sandscript is published by Stars and Sand. Stars and Sand is not a law firm. Nothing in this episode constitutes legal advice. All IP strategy decisions should be made in consultation with qualified patent counsel in the relevant jurisdictions.

Nintendo commands one of the most aggressive IP enforcement divisions in the consumer technology industry. In September 2025, it secured US Patent No. 12,403,397 — a divisional filing constructed in 2024 to retroactively target the mechanics of Palworld — and immediately deployed it in litigation at the Tokyo District Court. Six months later, the USPTO Central Reexamination Unit rejected all 26 claims. Not because of Palworld. Because of Nintendo's own paperwork.

This episode dissects that rejection at the architectural level. USPTO Director John A. Squires personally ordered an ex parte reexamination — the first Director-initiated review since 2012 to proceed without external request — signaling institutional scrutiny that goes well beyond a standard prior art dispute. The examiner then used four prior art filings to dismantle every claim: Nintendo's own Taura patent (2019), Nintendo's own Motokura patent (2020), Konami's Yabe patent (2002), and Bandai Namco's Shimomoto patent (2020). The Taura and Motokura references alone established what Nintendo itself knew and had already disclosed. The combination was enough.

We walk through the examiner's exact logic under 35 U.S.C. § 103, map each prior art reference to the specific claims it invalidated, and analyze Nintendo's most viable defense — the hindsight bias argument — and why it is structurally compromised by the fact that two of the four references are Nintendo's own.

By the end of this episode, you will understand why broad software patents are not moats — they are mapped territory. And why your own filing history may be the most dangerous prior art your legal team has not audited.

Stars and Sand is not a law firm and does not provide legal advice. This episode is for informational purposes only. Consult qualified patent counsel before making any IP decisions.

The America Invents Act promised a $500,000 alternative to $5,000,000 district court patent litigation. The Patent Trial and Appeal Board was that alternative. It no longer functions as one.